Imunon, Inc. (IMNN) stock
IMNNNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.63−0.01 (-1.22%)
Close on Nov 13, 2026Market cap $3.53MP/E –Yield –
Imunon total assets
Total assets on the balance sheet at the end of each period.
Imunon's total assets was $12.01M at Sep 30, 2026. For fiscal 2025 it was $12.29M, up 26.5% from the year before. Over ten years it grew -12.9% a year on average. The highest annual figure on record is $74.05M in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $12.29M | +26.5% |
| FY2024 | Dec 31, 2024 | $9.72M | -55.7% |
| FY2023 | Dec 31, 2023 | $21.92M | -50.2% |
| FY2022 | Dec 31, 2022 | $43.98M | -40.6% |
| FY2021 | Dec 31, 2021 | $74.05M | +97.3% |
| FY2020 | Dec 31, 2020 | $37.53M | -2.0% |
| FY2019 | Dec 31, 2019 | $38.28M | -18.3% |
| FY2018 | Dec 31, 2018 | $46.86M | -1.4% |
| FY2017 | Dec 31, 2017 | $47.51M | +54.0% |
| FY2016 | Dec 31, 2016 | $30.85M | -37.1% |
| FY2015 | Dec 31, 2015 | $49.03M | -26.5% |
| FY2014 | Dec 31, 2014 | $66.69M | +46.0% |
| FY2013 | Dec 31, 2013 | $45.67M | +80.1% |
| FY2012 | Dec 31, 2012 | $25.36M | -22.3% |
| FY2011 | Dec 31, 2011 | $32.65M | +1192.9% |
| FY2010 | Dec 31, 2010 | $2.53M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $12.01M | +36.6% |
| Q1 FY2026 | Mar 31, 2026 | $8.02M | +16.9% |
| Q4 FY2025 | Dec 31, 2025 | $12.29M | +26.5% |
| Q3 FY2025 | Sep 30, 2025 | $8.99M | -37.5% |
| Q2 FY2025 | Jun 30, 2025 | $8.79M | -9.3% |
| Q1 FY2025 | Mar 31, 2025 | $6.86M | -52.1% |
| Q4 FY2024 | Dec 31, 2024 | $9.72M | -55.7% |
| Q3 FY2024 | Sep 30, 2024 | $14.39M | -41.6% |
| Q2 FY2024 | Jun 30, 2024 | $9.69M | -66.3% |
| Q1 FY2024 | Mar 31, 2024 | $14.32M | -67.4% |
| Q4 FY2023 | Dec 31, 2023 | $21.92M | -63.8% |
| Q3 FY2023 | Sep 30, 2023 | $24.65M | -62.3% |
| Q2 FY2023 | Jun 30, 2023 | $28.72M | -55.4% |
| Q4 FY2022 | Dec 31, 2022 | $43.98M | -40.6% |
| Q3 FY2022 | Sep 30, 2022 | $60.53M | -23.8% |
| Q2 FY2022 | Jun 30, 2022 | $65.33M | -21.3% |
| Q1 FY2022 | Mar 31, 2022 | $64.34M | -11.9% |
| Q4 FY2021 | Dec 31, 2021 | $74.05M | +97.3% |
| Q3 FY2021 | Sep 30, 2021 | $79.47M | +113.2% |
| Q2 FY2021 | Jun 30, 2021 | $83.01M | +77.7% |
| Q1 FY2021 | Mar 31, 2021 | $73.04M | +87.6% |
| Q4 FY2020 | Dec 31, 2020 | $37.53M | -2.0% |
| Q3 FY2020 | Sep 30, 2020 | $37.27M | -8.1% |
| Q2 FY2020 | Jun 30, 2020 | $46.72M | +7.2% |
| Q1 FY2020 | Mar 31, 2020 | $38.94M | -14.2% |
| Q4 FY2019 | Dec 31, 2019 | $38.28M | -18.3% |
| Q3 FY2019 | Sep 30, 2019 | $40.56M | -0.9% |
| Q2 FY2019 | Jun 30, 2019 | $43.59M | -12.0% |
| Q1 FY2019 | Mar 31, 2019 | $45.40M | +3.2% |
| Q4 FY2018 | Dec 31, 2018 | $46.86M | -1.4% |
| Q3 FY2018 | Sep 30, 2018 | $40.91M | +57.3% |
| Q2 FY2018 | Jun 30, 2018 | $49.51M | +66.9% |
| Q1 FY2018 | Mar 31, 2018 | $44.00M | +42.9% |
| Q4 FY2017 | Dec 31, 2017 | $47.51M | +54.0% |
| Q3 FY2017 | Sep 30, 2017 | $26.00M | -30.6% |
| Q2 FY2017 | Jun 30, 2017 | $29.66M | -31.8% |
| Q1 FY2017 | Mar 31, 2017 | $30.80M | – |
| Q4 FY2016 | Dec 31, 2016 | $30.85M | – |
| Q3 FY2016 | Sep 30, 2016 | $37.46M | – |
| Q2 FY2016 | Jun 30, 2016 | $43.51M | – |
See a number that looks wrong?